Toxicities associated with CAR-T therapy compared with standard treatments in hematologic malignancies: a systematic review and meta-analysis
HematologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- BMC cancer
- Publicado em
- 2 mar 2026
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Toxicities associated with CAR-T therapy compared with standard treatments in hematologic malignancies: a systematic review and meta-analysis
Alexandra Porras-Ramírez, Alejandro Rico-Mendoza, Liliana Encinales, Oscar Madiedo, Marianna Carrillo Encinales, Juan Pablo Duque Bolívar, Juan Fernando Ramón-Cuellar, Jorge Andrés Urquijo Méndez, Alexandra Marín Morales, Zuly Moreno Perilla et al.
Descritores MeSH
- Immunotherapy, Adoptive
- Receptors, Chimeric Antigen
- Hematologic Neoplasms
- Hematopoietic Stem Cell Transplantation
- Humans
- Cytokine Release Syndrome
- Cytopenia
Veja também
Estudos relacionados
- Efficacy and Safety of Bendamustine Versus Fludarabine and Cyclophosphamide as Lymphodepleting Regimens for CAR-T Therapy in Hematological Malignancies: A Systematic Review and Meta-Analysis
- Comparison of regional differences in safety and efficacy of CAR-T therapy for hematologic malignancies in a real-world setting: a systematic review and meta-analysis
- Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-Analysis
- Biomarkers for Predicting Cytokine Release Syndrome following CD19-Targeted CAR T Cell Therapy